North America Continuous Glucose Monitoring Systems (CGMS) Market By Component (Sensors, Transmitters & Receivers, Integrated Insulin pumps), End User (Diagnostic centersclinics, ICUs, Home Healthcare)

North America Continuous Glucose Monitoring Systems (CGMS) Market By Component (Sensors, Transmitters & Receivers, Integrated Insulin pumps), End User (Diagnostic centersclinics, ICUs, Home Healthcare)

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Date of Publication -31-01-2017 | Number of Pages - 59 | Format - PDF


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Continuous Glucose Monitoring Systems Market, by Component
1.4.2 North America Continuous Glucose Monitoring Systems Market, by End User
1.4.3 North America Continuous Glucose Monitoring Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.2.3 Opportunities
2.3 North America Continuous Glucose Monitoring Systems Market - By Country
Chapter 3. North America Continuous Glucose Monitoring Systems Market - By Component
3.1 North America Continuous Glucose Monitoring Systems Sensors Market - By Country
3.2 North America Continuous Glucose Monitoring Transmitters & Receivers Market - By Country
3.3 North America Continuous Glucose Monitoring Systems Integrated Insulin pumps Market - By Country
Chapter 4. North America Continuous Glucose Monitoring Systems Market - By End User
4.1 North America Diagnostic centersclinics Continuous Glucose Monitoring Systems Market - By Country
4.2 North America ICUs Continuous Glucose Monitoring Systems Market - By Country
4.3 North America Home Healthcare Continuous Glucose Monitoring Systems Market - By Country
Chapter 5. North America Continuous Glucose Monitoring Systems Market - By Country
5.1 U.S Continuous Glucose Monitoring Systems Market
5.1.1 U.S Continuous Glucose Monitoring Systems Market - By Component
5.1.2 U.S Continuous Glucose Monitoring Systems Market - By End User
5.2 Canada Continuous Glucose Monitoring Systems Market
5.2.1 Canada Continuous Glucose Monitoring Systems Market - By Component
5.2.2 Canada Continuous Glucose Monitoring Systems Market - By End User
5.3 Mexico Continuous Glucose Monitoring Systems Market
5.3.1 Mexico Continuous Glucose Monitoring Systems Market - By Component
5.3.2 Mexico Continuous Glucose Monitoring Systems Market - By End User
5.4 Rest of North America Continuous Glucose Monitoring Systems Market
5.4.1 Rest of North America Continuous Glucose Monitoring Systems Market - By Component
5.4.2 Rest of North America Continuous Glucose Monitoring Systems Market - By End User
Chapter 6. Company Profile
6.1 Roche Diagnostics.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Analysis
6.2 Abbott Laboratories
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental Analysis
6.2.4 Research & Development Analysis
6.3 Dexcom, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Research & Development Analysis
6.4 Novo Nordisk.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Analysis
6.5 Ypsomed AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.6 GlySens Incorporated.
6.6.1 Company Overview
6.7 Medtronic Plc
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental Analysis
6.7.4 Research & Development Analysis
6.8 Johnson & Johnson.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Analysis
6.8.4 Segmental Analysis


Share



Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities